Community youth teams facilitating participatory adolescent groups, youth leadership activities and livelihood promotion to improve school attendance, dietary diversity and mental health among adolescent girls in rural eastern India: protocol for a cluster-randomised controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
08 Jan 2020
Historique:
received: 03 12 2018
accepted: 10 12 2019
entrez: 10 1 2020
pubmed: 10 1 2020
medline: 18 11 2020
Statut: epublish

Résumé

Improving the health and development of adolescents aged 10-19 years is a global health priority. One in five adolescents globally live in India. The Rashtriya Kishor Swasthya Karyakram (RKSK), India's national adolescent health strategy, recommends supporting community-based peer educators to conduct group meetings with boys and girls. Groups aim to give adolescents a space to discuss the social and health issues affecting them and build their capacity to become active community members and leaders. There have been no evaluations of the community component of RKSK to date. In this protocol, we describe the evaluation of the Jharkhand Initiative for Adolescent Health (JIAH), a community intervention aligned with RKSK and designed to improve school attendance, dietary diversity and mental health among adolescent girls aged 10-19 years in rural Jharkhand, eastern India. The JIAH intervention is delivered by a community youth team consisting of yuva saathis (friends of youth), youth leadership facilitators and livelihood promoters. Teams conduct (a) peer-led Participatory Learning and Action meetings with girls and boys, mobilising adolescents, parents, health workers, teachers and the wider community to make changes for adolescent health and development; (b) group-based youth leadership activities to build adolescents' confidence and resilience; and (c) livelihood promotion with adolescents and their families to provide training and practical skills. We are evaluating the JIAH intervention through a parallel-group, two-arm, superiority, cluster-randomised controlled trial. The unit of randomisation is a geographic cluster of ~1000 people. A total of 38 clusters covering an estimated population of 40,676 have been randomised to control or intervention arms. Nineteen intervention clusters have adolescent groups, youth leadership activities and livelihood promotion. Nineteen control clusters receive livelihood promotion only. Study participants are adolescent girls aged 10-19 years, married or unmarried, in or out of school, living in the study area. Intervention activities are open to all adolescent boys and girls, regardless of their participation in surveys. We will collect data through baseline and endline surveys. Primary trial outcomes are school attendance, dietary diversity and internalising and externalising mental health problems. Secondary outcomes include access to school-related entitlements, emotional or physical violence, self-efficacy and resilience. ISRCTN17206016. Registered on 27 June 2018.

Sections du résumé

BACKGROUND BACKGROUND
Improving the health and development of adolescents aged 10-19 years is a global health priority. One in five adolescents globally live in India. The Rashtriya Kishor Swasthya Karyakram (RKSK), India's national adolescent health strategy, recommends supporting community-based peer educators to conduct group meetings with boys and girls. Groups aim to give adolescents a space to discuss the social and health issues affecting them and build their capacity to become active community members and leaders. There have been no evaluations of the community component of RKSK to date. In this protocol, we describe the evaluation of the Jharkhand Initiative for Adolescent Health (JIAH), a community intervention aligned with RKSK and designed to improve school attendance, dietary diversity and mental health among adolescent girls aged 10-19 years in rural Jharkhand, eastern India.
METHODS METHODS
The JIAH intervention is delivered by a community youth team consisting of yuva saathis (friends of youth), youth leadership facilitators and livelihood promoters. Teams conduct (a) peer-led Participatory Learning and Action meetings with girls and boys, mobilising adolescents, parents, health workers, teachers and the wider community to make changes for adolescent health and development; (b) group-based youth leadership activities to build adolescents' confidence and resilience; and (c) livelihood promotion with adolescents and their families to provide training and practical skills. We are evaluating the JIAH intervention through a parallel-group, two-arm, superiority, cluster-randomised controlled trial. The unit of randomisation is a geographic cluster of ~1000 people. A total of 38 clusters covering an estimated population of 40,676 have been randomised to control or intervention arms. Nineteen intervention clusters have adolescent groups, youth leadership activities and livelihood promotion. Nineteen control clusters receive livelihood promotion only. Study participants are adolescent girls aged 10-19 years, married or unmarried, in or out of school, living in the study area. Intervention activities are open to all adolescent boys and girls, regardless of their participation in surveys. We will collect data through baseline and endline surveys. Primary trial outcomes are school attendance, dietary diversity and internalising and externalising mental health problems. Secondary outcomes include access to school-related entitlements, emotional or physical violence, self-efficacy and resilience.
TRIAL REGISTRATION BACKGROUND
ISRCTN17206016. Registered on 27 June 2018.

Identifiants

pubmed: 31915039
doi: 10.1186/s13063-019-3984-1
pii: 10.1186/s13063-019-3984-1
pmc: PMC6950906
doi:

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

52

Références

BMC Public Health. 2019 May 31;19(1):673
pubmed: 31151394
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
J Glob Health. 2019 Jun;9(1):010430
pubmed: 31448111
Lancet. 2016 Jun 11;387(10036):2423-78
pubmed: 27174304
BMJ. 2018 Mar 20;360:k1121
pubmed: 29559436
J Clin Epidemiol. 2012 Nov;65(11):1212-8
pubmed: 23017638
Stud Fam Plann. 1987 Mar-Apr;18(2):103-8
pubmed: 3590264
Lancet Glob Health. 2016 Feb;4(2):e119-28
pubmed: 26823213
BMC Public Health. 2019 Jul 18;19(1):962
pubmed: 31319828
PLoS One. 2019 Jan 23;14(1):e0210468
pubmed: 30673732
BMJ. 2017 Apr 11;357:j1309
pubmed: 28400363
Soc Sci Med. 2016 Jul;161:37-46
pubmed: 27239706
Soc Sci Med. 2014 Nov;120:169-79
pubmed: 25254614
AIDS Educ Prev. 2009 Jun;21(3):181-206
pubmed: 19519235
J Adolesc. 2015 Dec;45:284-95
pubmed: 26547145
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Lancet. 2010 Apr 3;375(9721):1182-92
pubmed: 20207411
J Adolesc Health. 2011 May;48(5):453-60
pubmed: 21501803
SAHARA J. 2007 Nov;4(3):678-94
pubmed: 18185895
Lancet Glob Health. 2017 Oct;5(10):e1004-e1016
pubmed: 28911749
Lancet. 2018 Dec 8;392(10163):2465-2477
pubmed: 30473365

Auteurs

Suchitra Rath (S)

Ekjut, Chakradharpur, Jharkhand, India.

Audrey Prost (A)

Institute for Global Health, University College London, London, UK.

Subhashree Samal (S)

Ekjut, Chakradharpur, Jharkhand, India.

Hemanta Pradhan (H)

Ekjut, Chakradharpur, Jharkhand, India.

Andrew Copas (A)

Institute for Global Health, University College London, London, UK.

Sumitra Gagrai (S)

Ekjut, Chakradharpur, Jharkhand, India.

Shibanand Rath (S)

Ekjut, Chakradharpur, Jharkhand, India.

Raj Kumar Gope (RK)

Ekjut, Chakradharpur, Jharkhand, India.

Nirmala Nair (N)

Ekjut, Chakradharpur, Jharkhand, India.

Prasanta Tripathy (P)

Ekjut, Chakradharpur, Jharkhand, India.

Komal Bhatia (K)

Institute for Global Health, University College London, London, UK.

Kelly Rose-Clarke (K)

Department of Global Health and Social Medicine, King's College London, Bush House NE Wing, London, WC2B 4BG, UK. kelly.rose-clarke@kcl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH